| 000032 (2020) |
Ming Niu [République populaire de Chine] ; Rui-Lin Wang [République populaire de Chine] ; Zhong-Xia Wang [République populaire de Chine] ; Ping Zhang [République populaire de Chine] ; Zhao-Fang Bai [République populaire de Chine] ; Jing Jing [République populaire de Chine] ; Yu-Ming Guo [République populaire de Chine] ; Xu Zhao [République populaire de Chine] ; Xiao-Yan Zhan [République populaire de Chine] ; Zi-Teng Zhang [République populaire de Chine] ; Xue-Ai Song [République populaire de Chine] ; En-Qiang Qin [République populaire de Chine] ; Jia-Bo Wang [République populaire de Chine] ; Xiao-He Xiao [République populaire de Chine] | [Rapid establishment of traditional Chinese medicine prevention and treatment of 2019-nCoV based on clinical experience and molecular docking]. |
| 000101 (2020) |
Yang Yang ; Md Sahidul Islam ; Jin Wang ; Yuan Li ; Xin Chen | Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective |
| 000044 (2020) |
Rong-Sheng Luan [République populaire de Chine] ; Xin Wang [République populaire de Chine] ; Xin Sun [République populaire de Chine] ; Xing-Shu Chen [République populaire de Chine] ; Tao Zhou [République populaire de Chine] ; Quan-Hui Liu [République populaire de Chine] ; Xin Lü [République populaire de Chine] ; Xian-Ping Wu [République populaire de Chine] ; Dong-Qing Gu [République populaire de Chine] ; Ming-Shuang Tang [République populaire de Chine] ; Hui-Jie Cui [République populaire de Chine] ; Xue-Feng Shan [République populaire de Chine] ; Jing Ouyang [République populaire de Chine] ; Ben Zhang [République populaire de Chine] ; Wei Zhang [République populaire de Chine] ; Emergency Research Group Sichuan University Covid- [République populaire de Chine] | [Epidemiology, Treatment, and Epidemic Prevention and Control of the Coronavirus Disease 2019: a Review]. |
| 000100 (2020) |
Chang-Quan Ling | Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2) |
| 000407 (2020) |
Di Wu [République populaire de Chine] ; Jianyun Lu [République populaire de Chine] ; Yanhui Liu [République populaire de Chine] ; Zhoubin Zhang [République populaire de Chine] ; Lei Luo [République populaire de Chine] | Positive effects of COVID-19 control measures on influenza prevention. |
| 000458 (2020) |
Shengwei Yu [République populaire de Chine] ; Junwu Wang [République populaire de Chine] ; Haitao Shen [République populaire de Chine] | Network pharmacology-based analysis of the role of traditional Chinese herbal medicines in the treatment of COVID-19. |
| 000883 (2020) |
Hui Luo [République populaire de Chine] ; Qiao-Ling Tang [République populaire de Chine] ; Ya-Xi Shang [République populaire de Chine] ; Shi-Bing Liang [République populaire de Chine] ; Ming Yang [République populaire de Chine] ; Nicola Robinson [République populaire de Chine] ; Jian-Ping Liu [République populaire de Chine] | Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs |
| 000A57 (2020) |
T M Wassenaar [Allemagne] ; Y. Zou [République populaire de Chine] | 2019_nCoV/SARS-CoV-2: rapid classification of betacoronaviruses and identification of Traditional Chinese Medicine as potential origin of zoonotic coronaviruses. |
| 000011 (2020-02-13) |
Sibylle Bernard-Stoecklin [France] ; Patrick Rolland [France] ; Yassoungo Silue [France] ; Alexandra Mailles [France] ; Christine Campese [France] ; Anne Simondon [France] ; Matthieu Mechain [France] ; Laure Meurice [France] ; Mathieu Nguyen [France] ; Clément Bassi [France] ; Estelle Yamani [France] ; Sylvie Behillil [France] ; Sophie Ismael [France] ; Duc Nguyen [France] ; Denis Malvy [France] ; François-Xavier Lescure [France] ; Scarlett Georges [France] ; Clément Lazarus [France] ; Anouk Tabaï [France] ; Morgane Stempfelet [France] ; Vincent Enouf [France] ; Bruno Coignard [France] ; Daniel Levy-Bruhl [France] | First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020 |
| 000029 (2020) |
Yu-Shi Zhang [République populaire de Chine] ; Wei-Hong Cong [République populaire de Chine] ; Jing-Jing Zhang [République populaire de Chine] ; Fei-Fei Guo [République populaire de Chine] ; Hong-Mei Li [République populaire de Chine] | [Research progress of intervention of Chinese herbal medicine and its active components on human coronavirus]. |
| 000037 (2020) |
| [Perinatal and neonatal management plan for prevention and control of SARS-CoV-2 infection (2nd Edition)]. |
| 000043 (2020) |
Specialized Committee Of Neurogenetics Neurophysician Branch Of Chinese Medical Doctor Association [République populaire de Chine] ; Hong Jiang ; Beisha Tang | [Expert consensus on the management strategy of patients with hereditary ataxia during prevention and control of novel coronavirus pneumonia epidemic]. |
| 000050 (2020) |
Cai-Xia Yan [République populaire de Chine] ; Jia Li [République populaire de Chine] ; Xin Shen [République populaire de Chine] ; Li Luo [République populaire de Chine] ; Yan Li [République populaire de Chine] ; Ming-Yuan Li [République populaire de Chine] | [Biological Product Development Strategies for Prevention and Treatment of Coronavirus Disease 2019]. |
| 000054 (2020) |
Lai-Shuan Wang [République populaire de Chine] ; Xiao-Jing Hu ; Wen-Hao Zhou | [An interpretation on perinatal and neonatal management plan for prevention and control of SARS-CoV-2 infection (2nd Edition)]. |
| 000089 (2020) |
Yixuan Wang [République populaire de Chine] ; Yuyi Wang [République populaire de Chine] ; Yan Chen [République populaire de Chine] ; Qingsong Qin [République populaire de Chine] | Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. |
| 000095 (2020) |
Mingxiang Ye [République populaire de Chine] ; Dian Fu [République populaire de Chine] ; Yi Ren [République populaire de Chine] ; Faxiang Wang [République populaire de Chine] ; Dong Wang [République populaire de Chine] ; Fang Zhang [République populaire de Chine] ; Xinyi Xia [République populaire de Chine] ; Tangfeng Lv [République populaire de Chine] | Treatment with convalescent plasma for COVID-19 patients in Wuhan, China. |
| 000127 (2020) |
Sheng Zhang [République populaire de Chine] ; Meng Yuan Diao ; Liwei Duan [République populaire de Chine] ; Zhaofen Lin [République populaire de Chine] ; Dechang Chen [République populaire de Chine] | The novel coronavirus (SARS-CoV-2) infections in China: prevention, control and challenges |
| 000166 (2020) |
Yuxin Yan [République populaire de Chine] ; Woo In Shin [Malaisie] ; Yoong Xin Pang [République populaire de Chine] ; Yang Meng [République populaire de Chine] ; Jianchen Lai [République populaire de Chine] ; Chong You [République populaire de Chine] ; Haitao Zhao [États-Unis] ; Edward Lester [Royaume-Uni] ; Tao Wu [République populaire de Chine] ; Cheng Heng Pang [République populaire de Chine] | The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment. |
| 000208 (2020) |
Jia Wang [République populaire de Chine] ; Zhifeng Wang [République populaire de Chine] | Strengths, Weaknesses, Opportunities and Threats (SWOT) Analysis of China's Prevention and Control Strategy for the COVID-19 Epidemic. |
| 000271 (2020) |
Chenyu Li [Allemagne] ; Paola Romagnani [Italie] ; Albrecht Von Brunn [Allemagne] ; Hans-Joachim Anders [Allemagne] | SARS-CoV-2 and Europe: timing of containment measures for outbreak control |
| 000343 (2020) |
Barbara Nussbaumer-Streit ; Verena Mayr ; Andreea Iulia Dobrescu ; Andrea Chapman ; Emma Persad ; Irma Klerings ; Gernot Wagner ; Uwe Siebert [Autriche] ; Claudia Christof ; Casey Zachariah ; Gerald Gartlehner | Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review. |
| 000499 (2020) |
Fujun Peng [République populaire de Chine] ; Lei Tu [République populaire de Chine] ; Yongshi Yang [République populaire de Chine] ; Peng Hu [République populaire de Chine] ; Runsheng Wang [République populaire de Chine] ; Qinyong Hu [République populaire de Chine] ; Feng Cao [République populaire de Chine] ; Taijiao Jiang [République populaire de Chine] ; Jinlyu Sun [République populaire de Chine] ; Guogang Xu [République populaire de Chine] ; Christopher Chang [États-Unis] | Management and Treatment of COVID-19: The Chinese Experience |
| 000501 (2020) |
Juan Yu [République populaire de Chine] ; Ning Ding [République populaire de Chine] ; Huan Chen [République populaire de Chine] ; Xia-Jing Liu [République populaire de Chine] ; Zu-Hui Pu [République populaire de Chine] ; Hua-Jian Xu [République populaire de Chine] ; Yi Lei [République populaire de Chine] ; Han-Wen Zhang [République populaire de Chine] | Loopholes in Current Infection Control and Prevention Practices Against COVID-19 in Radiology Department and Improvement Suggestions. |
| 000511 (2020) |
Jared S. Morse ; Tyler Lalonde ; Shiqing Xu ; Wenshe Ray Liu | Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019‐nCoV† |
| 000533 (2020) |
Muh-Yong Yen [Taïwan] ; Jonathan Schwartz [États-Unis] ; Shey-Ying Chen [Taïwan] ; Chwan-Chuen King [Taïwan] ; Guang-Yang Yang [Taïwan] ; Po-Ren Hsueh [Taïwan] | Interrupting COVID-19 transmission by implementing enhanced traffic control bundling: Implications for global prevention and control efforts |
| 000556 (2020) |
Shawn D. Keil [États-Unis] ; Izabela Ragan ; Susan Yonemura [États-Unis] ; Lindsay Hartson [États-Unis] ; Nicole K. Dart [États-Unis] ; Richard Bowen | Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light-based photochemical treatment. |
| 000563 (2020) |
Chad R. Wells ; Pratha Sah ; Seyed M. Moghadas [Canada] ; Abhishek Pandey ; Affan Shoukat ; Yaning Wang [République populaire de Chine] ; Zheng Wang ; Lauren A. Meyers ; Burton H. Singer ; Alison P. Galvani | Impact of international travel and border control measures on the global spread of the novel 2019 coronavirus outbreak |
| 000596 (2020) |
Andrew T. Day [États-Unis] ; David J. Sher [États-Unis] ; Rebecca C. Lee [États-Unis] ; John M. Truelson [États-Unis] ; Larry L. Myers [États-Unis] ; Baran D. Sumer [États-Unis] ; Lenka Stankova [États-Unis] ; Brittny N. Tillman [États-Unis] ; Randall S. Hughes [États-Unis] ; Saad A. Khan [États-Unis] ; Eli A. Gordin [États-Unis] | Head and neck oncology during the COVID-19 pandemic: Reconsidering traditional treatment paradigms in light of new surgical and other multilevel risks |
| 000635 (2020) |
Sibylle Bernard Stoecklin [France] ; Patrick Rolland [France] ; Yassoungo Silue [France] ; Alexandra Mailles [France] ; Christine Campese [France] ; Anne Simondon [France] ; Matthieu Mechain [France] ; Laure Meurice [France] ; Mathieu Nguyen [France] ; Clément Bassi [France] ; Estelle Yamani [France] ; Sylvie Behillil [France] ; Sophie Ismael [France] ; Duc Nguyen [France] ; Denis Malvy [France] ; François Xavier Lescure [France] ; Scarlett Georges [France] ; Clément Lazarus [France] ; Anouk Tabaï [France] ; Morgane Stempfelet [France] ; Vincent Enouf [France] ; Bruno Coignard [France] ; Daniel Levy-Bruhl [France] | First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020 |
| 000790 (2020) |
Jaime A. Teixeira Da Silva | Convalescent plasma: A possible treatment of COVID-19 in India |
| 000813 (2020) |
Pierre Tiberghien [France] ; Xavier De Lambalerie [France] ; Pascal Morel [France] ; Pierre Gallian [France] ; Karine Lacombe [France] ; Yazdan Yazdanpanah [France] | Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how. |
| 000902 (2020) |
Kam Wa Chan [Hong Kong] ; Vivian Taam Wong [Hong Kong] ; Sydney Chi Wai Tang [Hong Kong] | COVID-19: An Update on the Epidemiological, Clinical, Preventive and Therapeutic Evidence and Guidelines of Integrative Chinese-Western Medicine for the Management of 2019 Novel Coronavirus Disease. |
| 000941 (2020) |
Camillo Sargiacomo [Royaume-Uni] ; Federica Sotgia [Royaume-Uni] ; Michael P. Lisanti [Royaume-Uni] | COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection? |
| 000A86 (2007) |
Franz X. Lackner [Autriche] | Disinfection for prevention and control of infections on the threshold of the 21st century for the critically ill patient |
| 000A93 (2006) |
J. L. Heeney [Pays-Bas] | Zoonotic viral diseases and the frontier of early diagnosis, control and prevention |
| 000B14 (????) |
Mahdi Asghari Ozma [Iran] ; Parham Maroufi [Iran] ; Ehsaneh Khodadadi [Iran] ; Kran Köse [Turquie] ; Isabella Esposito [Italie] ; Khudaverdi Ganbarov ; Sounkalo Dao [Mali] ; Silvano Esposito [Italie] ; Tuba Dal [Turquie] ; Elham Zeinalzadeh [Iran] ; Hossein Samadi Kafil [Iran] | Clinical manifestation, diagnosis, prevention and control of SARS-CoV-2 (COVID-19) during the outbreak period. |
| 000040 (2020) |
X. Wang [République populaire de Chine] ; Y Q Ding [République populaire de Chine] | [From SARS to COVID-19: pathogens, receptor, pathogenesis and principles of the treatment]. |
| 000055 (2020) |
J. Wang [République populaire de Chine] ; B J Wang [République populaire de Chine] ; J C Yang [République populaire de Chine] ; M Y Wang [République populaire de Chine] ; C. Chen [République populaire de Chine] ; G X Luo [République populaire de Chine] ; W F He [République populaire de Chine] | [Advances in the research of mechanism of pulmonary fibrosis induced by Corona Virus Disease 2019 and the corresponding therapeutic measures]. |
| 000062 (2020) |
Binqing Fu [République populaire de Chine] ; Xiaoling Xu [République populaire de Chine] ; Haiming Wei [République populaire de Chine] | Why tocilizumab could be an effective treatment for severe COVID-19? |
| 000075 (2020) |
Tuan M. Nguyen [États-Unis] ; Yang Zhang [États-Unis] ; Pier Paolo Pandolfi [États-Unis] | Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses. |
| 000078 (2020) |
Yuefei Jin [République populaire de Chine] ; Haiyan Yang [République populaire de Chine] ; Wangquan Ji [République populaire de Chine] ; Weidong Wu [République populaire de Chine] ; Shuaiyin Chen [République populaire de Chine] ; Weiguo Zhang [République populaire de Chine] ; Guangcai Duan [République populaire de Chine] | Virology, Epidemiology, Pathogenesis, and Control of COVID-19. |
| 000085 (2020) |
Jin Young Ahn [Corée du Sud] ; Yujin Sohn [Corée du Sud] ; Su Hwan Lee [Corée du Sud] ; Yunsuk Cho [Corée du Sud] ; Jong Hoon Hyun [Corée du Sud] ; Yae Jee Baek [Corée du Sud] ; Su Jin Jeong [Corée du Sud] ; Jung Ho Kim [Corée du Sud] ; Nam Su Ku [Corée du Sud] ; Joon Sup Yeom [Corée du Sud] ; Juhye Roh [Corée du Sud] ; Mi Young Ahn [Corée du Sud] ; Bum Sik Chin [Corée du Sud] ; Young Sam Kim [Corée du Sud] ; Hyukmin Lee [Corée du Sud] ; Dongeun Yong [Corée du Sud] ; Hyun Ok Kim [Corée du Sud] ; Sinyoung Kim [Corée du Sud] ; Jun Yong Choi [Corée du Sud] | Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea. |
| 000091 (2020) |
Erwan Sallard [France] ; François-Xavier Lescure [France] ; Yazdan Yazdanpanah [France] ; France Mentre [France] ; Nathan Peiffer-Smadja [France] | Type 1 interferons as a potential treatment against COVID-19 |
| 000092 (2020) |
Vineet D. Menachery [États-Unis] ; Kenneth H. Dinnon [États-Unis] ; Boyd L. Yount [États-Unis] ; Eileen T. Mcanarney [États-Unis] ; Lisa E. Gralinski [États-Unis] ; Andrew Hale [États-Unis] ; Rachel L. Graham [États-Unis] ; Trevor Scobey [États-Unis] ; Simon J. Anthony [États-Unis] ; Lingshu Wang [États-Unis] ; Barney Graham [États-Unis] ; Scott H. Randell [États-Unis] ; W Ian Lipkin [États-Unis] ; Ralph S. Baric [États-Unis] | Trypsin Treatment Unlocks Barrier for Zoonotic Bat Coronavirus Infection. |
| 000114 (2020) |
Yu Han [République populaire de Chine] ; Hailan Yang [République populaire de Chine] | The transmission and diagnosis of 2019 novel coronavirus infection disease (COVID-19): A Chinese perspective. |
| 000117 (2020) |
Luca Mascaretti [Italie] ; Vincenzo De Angelis [Italie] ; Pierluigi Berti [Italie] | The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic and Transfusion Medicine: reflections from Italy |
| 000122 (2020) |
Qing Ye [République populaire de Chine] ; Bili Wang [République populaire de Chine] ; Jianhua Mao [République populaire de Chine] | The pathogenesis and treatment of the `Cytokine Storm' in COVID-19. |
| 000135 (2020) |
Pan Zhai [République populaire de Chine] ; Yanbing Ding [République populaire de Chine] ; Xia Wu [République populaire de Chine] ; Junke Long [République populaire de Chine] ; Yanjun Zhong [République populaire de Chine] ; Yiming Li [République populaire de Chine] | The epidemiology, diagnosis and treatment of COVID-19 |
| 000141 (2020) |
Kiesha Prem [Royaume-Uni] ; Yang Liu [Royaume-Uni] ; Timothy W. Russell [Royaume-Uni] ; Adam J. Kucharski [Royaume-Uni] ; Rosalind M. Eggo [Royaume-Uni] ; Nicholas Davies [Royaume-Uni] ; Mark Jit [Royaume-Uni] ; Petra Klepac [Royaume-Uni] | The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study |
| 000144 (2020) |
Wenzheng Han [République populaire de Chine] ; Bin Quan [République populaire de Chine] ; Yi Guo [République populaire de Chine] ; Jun Zhang [République populaire de Chine] ; Yong Lu [République populaire de Chine] ; Gang Feng [République populaire de Chine] ; Qiwen Wu [République populaire de Chine] ; Fang Fang [République populaire de Chine] ; Long Cheng [République populaire de Chine] ; Nanlin Jiao [République populaire de Chine] ; Xiaoning Li [République populaire de Chine] ; Qing Chen [République populaire de Chine] | The course of clinical diagnosis and treatment of a case infected with coronavirus disease 2019. |
| 000149 (2020) |
Y J Duan [République populaire de Chine] ; Q. Liu [République populaire de Chine] ; S Q Zhao [République populaire de Chine] ; F. Huang [République populaire de Chine] ; L. Ren [République populaire de Chine] ; L. Liu [République populaire de Chine] ; Y W Zhou [République populaire de Chine] | The Trial of Chloroquine in the Treatment of Corona Virus Disease 2019 （COVID-19） and Its Research Progress in Forensic Toxicology. |
| 000164 (2020) |
| The Impact and Control of Emerging and Re-Emerging Viral Diseases in the Environment: An African Perspective |
| 000180 (2020) |
Jean Christophe Lagier [France] ; Philippe Colson [France] ; Hervé Tissot Dupont [France] ; Jérôme Salomon [France] ; Barbara Doudier [France] ; Camille Aubry [France] ; Frédérique Gouriet [France] ; Sophie Baron [France] ; Pierre Dudouet [France] ; Rémi Flores [France] ; Lucie Ailhaud [France] ; Philippe Gautret [France] ; Philippe Parola [France] ; Bernard La Scola [France] ; Didier Raoult [France] ; Philippe Brouqui [France] | Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine? |
| 000183 (2020) |
Sophie Alexandra Baron [France] ; Christian Devaux [France] ; Philippe Colson [France] ; Didier Raoult [France] ; Jean-Marc Rolain [France] | Teicoplanin: an alternative drug for the treatment of coronavirus COVID-19? |
| 000254 (2020) |
Di Mauro Gabriella ; Scavone Cristina ; Rafaniello Concetta ; Rossi Francesco ; Capuano Annalisa | SARS-Cov-2 infection: response of human immune system and possible implications for the rapid test and treatment |
| 000279 (2020) |
Jie Wang ; Haiting Feng [République populaire de Chine] ; Sheng Zhang [République populaire de Chine] ; Zuowei Ni [République populaire de Chine] ; Lingmei Ni [République populaire de Chine] ; Yu Chen [République populaire de Chine] ; Lixin Zhuo ; Zifeng Zhong [République populaire de Chine] ; Tingting Qu [République populaire de Chine] | SARS-CoV-2 RNA detection of hospital isolation wards hygiene monitoring during the Coronavirus Disease 2019 outbreak in a Chinese hospital. |
| 000281 (2020) |
Eskild Petersen | SARS-CoV-2 Epidemiology and Control, Different Scenarios for Turkey. |
| 000286 (2020) |
Michele Costanzo ; Maria Anna Rachele De Giglio ; Giovanni Nicola Roviello | SARS CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and Other Drugs for the Treatment of the New Coronavirus. |
| 000300 (2020) |
Ashley Barlow [États-Unis] ; Kaitlin M. Landolf [États-Unis] ; Brooke Barlow [États-Unis] ; Siu Yan Amy Yeung [États-Unis] ; Jason J. Heavner [États-Unis] ; Cassidy W. Claassen [Zambie] ; Mojdeh S. Heavner [États-Unis] | Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019. |
| 000322 (2020) |
Giuseppe Curigliano [Italie] ; Maria Joao Cardoso [Portugal] ; Philip Poortmans [France] ; Oreste Gentilini [Italie] ; Gabriella Pravettoni [Italie] ; Ketti Mazzocco [Italie] ; Nehmat Houssami [Australie] ; Olivia Pagani [Suisse] ; Elzbieta Senkus [Pologne] ; Fatima Cardoso | Recommendations for Triage, Prioritization and Treatment of Breast Cancer Patients During the COVID-19 Pandemic |
| 000329 (2020) |
Shuntong Kang [République populaire de Chine] ; Wenyao Peng [République populaire de Chine] ; Yuhao Zhu [République populaire de Chine] ; Shiyao Lu [République populaire de Chine] ; Min Zhou [République populaire de Chine] ; Wei Lin [République populaire de Chine] ; Wenfang Wu [République populaire de Chine] ; Shu Huang [République populaire de Chine] ; Liping Jiang [République populaire de Chine] ; Xuan Luo [République populaire de Chine] ; Meichun Deng [République populaire de Chine] | Recent progress in understanding 2019 novel coronavirus (SARS-CoV-2) associated with human respiratory disease: detection, mechanisms and treatment |
| 000344 (2020) |
Luca Ferretti [Royaume-Uni] ; Chris Wymant [Royaume-Uni] ; Michelle Kendall [Royaume-Uni] ; Lele Zhao [Royaume-Uni] ; Anel Nurtay [Royaume-Uni] ; Lucie Abeler-Dörner [Royaume-Uni] ; Michael Parker [Royaume-Uni] ; David Bonsall [Royaume-Uni] ; Christophe Fraser [Royaume-Uni] | Quantifying SARS-CoV-2 transmission suggests epidemic control with digital
contact tracing |
| 000354 (2020) |
Pengcheng Zhou [République populaire de Chine] ; Zebing Huang [République populaire de Chine] ; Yinzong Xiao [République populaire de Chine] ; Xun Huang [République populaire de Chine] ; Xue-Gong Fan [République populaire de Chine] | Protecting Chinese Healthcare Workers While Combating the 2019 Novel Coronavirus. |
| 000356 (2020) |
Emmie De Wit ; Friederike Feldmann ; Jacqueline Cronin ; Robert Jordan ; Atsushi Okumura ; Tina Thomas ; Dana Scott ; Tomas Cihlar ; Heinz Feldmann | Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection |
| 000385 (2020) |
Giuseppe Rombolà [Italie] ; Marco Hedemperger [Italie] ; Luciano Pedrini [Italie] ; Marco Farina [Italie] ; Filippo Aucella [Italie] ; Piergiorgio Messa [Italie] ; Giuliano Brunori [Italie] | Practical indications for the prevention and management of SARS-CoV-2 in ambulatory dialysis patients: lessons from the first phase of the epidemics in Lombardy |
| 000415 (2020) |
Laure Elens [Belgique] ; Loralie J. Langman [États-Unis] ; Dennis A. Hesselink [Pays-Bas] ; Stein Bergan [Norvège] ; Dirk Jan A R. Moes [Pays-Bas] ; Mariadelfina Molinaro [Italie] ; Raman Venkataramanan [États-Unis] ; Florian Lemaitre [France] | Pharmacologic treatment of transplant recipients infected with SARS-CoV-2: considerations regarding therapeutic drug monitoring and drug-drug interactions. |
| 000432 (2020) |
Peong Gang Park [Corée du Sud] ; Chang Hyup Kim [Corée du Sud] ; Yoon Heo [Corée du Sud] ; Tae Suk Kim [Corée du Sud] ; Chan Woo Park [Corée du Sud] ; Choong Hyo Kim [Corée du Sud] | Out-of-Hospital Cohort Treatment of Coronavirus Disease 2019 Patients with Mild Symptoms in Korea: an Experience from a Single Community Treatment Center. |
| 000434 (2020) |
Henrik Sjödin [Suède] ; Annelies Wilder-Smith [Allemagne] ; Sarah Osman [Suède] ; Zia Farooq [Suède] ; Joacim Rocklöv [Suède] | Only strict quarantine measures can curb the coronavirus disease (COVID-19) outbreak in Italy, 2020. |
| 000450 (2020) |
Subramanian Boopathi [Chili] ; Adolfo B. Poma [Pologne] ; Ponmalai Kolandaivel [Inde] | Novel 2019 Coronavirus Structure, Mechanism of Action, Antiviral drug promises and rule out against its treatment. |
| 000455 (2020) |
Scott P. Layne [États-Unis] ; James M. Hyman [États-Unis] ; David M. Morens [États-Unis] ; Jeffery K. Taubenberger [États-Unis] | New coronavirus outbreak: Framing questions for pandemic prevention. |
| 000522 (2020) |
A. Wilder-Smith [Royaume-Uni, Allemagne] ; D O Freedman [États-Unis] | Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak |
| 000530 (2020) |
Rachael Pung [Singapour] ; Calvin J. Chiew [Singapour] ; Barnaby E. Young [Singapour] ; Sarah Chin [Singapour] ; Mark I-C Chen [Singapour] ; Hannah E. Clapham [Singapour] ; Alex R. Cook [Singapour] ; Sebastian Maurer-Stroh [Singapour] ; Matthias P H S. Toh [Singapour] ; Cuiqin Poh [Singapour] ; Mabel Low [Singapour] ; Joshua Lum [Singapour] ; Valerie T J. Koh [Singapour] ; Tze M. Mak [Singapour] ; Lin Cui [Singapour] ; Raymond V T P. Lin [Singapour] ; Derrick Heng [Singapour] ; Yee-Sin Leo [Singapour] ; David C. Lye [Singapour] ; Vernon J M. Lee [Singapour] | Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures. |
| 000536 (2020) |
M. Bizzarri [Italie] ; A S Laganà ; D. Aragona ; V. Unfer | Inositol and pulmonary function. Could myo-inositol treatment downregulate inflammation and cytokine release syndrome in SARS-CoV-2? |
| 000538 (2020) |
Yuri Bruinen De Bruin [Italie] ; Anne-Sophie Lequarre [Italie] ; Josephine Mccourt [Italie] ; Peter Clevestig [Émirats arabes unis] ; Filippo Pigazzani [Royaume-Uni] ; Maryam Zare Jeddi [Italie] ; Claudio Colosio [Italie] ; Margarida Goulart [Italie] | Initial impacts of global risk mitigation measures taken during the combatting of the COVID-19 pandemic |
| 000549 (2020) |
Juan Yu [République populaire de Chine] ; Ning Ding [République populaire de Chine] ; Huan Chen [République populaire de Chine] ; Xia-Jing Liu [République populaire de Chine] ; Wen-Jie He [République populaire de Chine] ; Wei-Cai Dai [République populaire de Chine] ; Zhao-Guang Zhou [République populaire de Chine] ; Fan Lin [République populaire de Chine] ; Zu-Hui Pu [République populaire de Chine] ; Ding-Fu Li [République populaire de Chine] ; Hua-Jian Xu [République populaire de Chine] ; Yu-Li Wang [République populaire de Chine] ; Han-Wen Zhang [République populaire de Chine] ; Yi Lei [République populaire de Chine] | Infection Control against COVID-19 in Departments of Radiology |
| 000555 (2020) |
Markus Eickmann [Allemagne] ; Ute Gravemann [Allemagne] ; Wiebke Handke [Allemagne] ; Frank Tolksdorf [Allemagne] ; Stefan Reichenberg [Allemagne] ; Thomas H. Müller [Allemagne] ; Axel Seltsam [Allemagne] | Inactivation of three emerging viruses - severe acute respiratory syndrome coronavirus, Crimean-Congo haemorrhagic fever virus and Nipah virus - in platelet concentrates by ultraviolet C light and in plasma by methylene blue plus visible light. |
| 000561 (2020) |
Sudipto Chatterjee | Important Steps to Control COVID-19/SARS-CoV-2 Infection. |
| 000562 (2020) |
Wolf Schweitzer [Suisse] ; Thomas Ruder [Suisse] ; Rilana Baumeister [Suisse] ; Stephan Bolliger [Suisse] ; Michael Thali [Suisse] ; Eva Meixner [Suisse] ; Garyfalia Ampanozi [Suisse] | Implications for forensic death investigations from first Swiss case of non-hospital treatment with COVID-19 |
| 000570 (2020) |
Thomas R. Frieden ; Christopher T. Lee | Identifying and Interrupting Superspreading Events-Implications for Control of Severe Acute Respiratory Syndrome Coronavirus 2. |
| 000582 (2020) |
Philippe Gautret [France] ; Jean-Christophe Lagier [France] ; Philippe Parola [France] ; Van Thuan Hoang [France, Viêt Nam] ; Line Meddeb [France] ; Morgane Mailhe [France] ; Barbara Doudier [France] ; Johan Courjon [France] ; Valérie Giordanengo [France] ; Vera Esteves Vieira [France] ; Hervé Tissot Dupont [France] ; Stéphane Honoré [France] ; Philippe Colson [France] ; Eric Chabrière [France] ; Bernard La Scola [France] ; Jean-Marc Rolain [France] ; Philippe Brouqui [France] ; Didier Raoult [France] | Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial |
| 000630 (2020) |
Ondrej Hrusak ; Tomas Kalina ; Joshua Wolf [États-Unis] ; Adriana Balduzzi [Italie] ; Massimo Provenzi [Italie] ; Carmelo Rizzari ; Susana Rives [Espagne] ; María Del Pozo Carlavilla [Espagne] ; Maria Eli Valerio Alonso [Espagne] ; Nerea Domínguez Pinilla [Espagne] ; Jean-Pierre Bourquin [Suisse] ; Kjeld Schmiegelow [Danemark] ; Andishe Attarbaschi [Autriche] ; Pernilla Grillner [Suède] ; Karin Mellgren [Suède] ; J. Ten Bosch Van Der Werff [Belgique] ; Rob Pieters [Pays-Bas] ; Triantafyllia Brozou ; Arndt Borkhardt ; Gabriele Escherich [Allemagne] ; Melchior Lauten [Allemagne] ; Martin Stanulla [Allemagne] ; Owen Smith [Irlande (pays)] ; Allen Eng Juh Yeoh [Singapour] ; Sarah Elitzur ; Ajay Vora [Royaume-Uni] ; Chi-Kong Li [Hong Kong] ; Hany Ariffin [Malaisie] ; Alexandra Kolenova [Slovaquie] ; Luciano Dallapozza [Australie] ; Roula Farah [Liban] ; Jelena Lazic [Serbie] ; Atsushi Manabe [Japon] ; Jan Styczynski [Pologne] ; Gabor Kovacs [Hongrie] ; Gabor Ottoffy [Hongrie] ; Marisa Felice [Argentine] ; Barbara Buldini [Italie] ; Valentino Conter [Italie] ; Jan Stary ; Martin Schrappe [Allemagne] | Flash Survey on SARS-CoV-2 Infections in Pediatric Patients on anti-Cancer Treatment |
| 000645 (2020) |
Huai-Liang Wu [République populaire de Chine] ; Jian Huang [Royaume-Uni] ; Casper J. P. Zhang [République populaire de Chine] ; Zonglin He [République populaire de Chine] ; Wai-Kit Ming [République populaire de Chine] | Facemask shortage and the novel coronavirus disease (COVID-19) outbreak: Reflections on public health measures |
| 000697 (2020) |
Franck Katembo Sikakulya ; Olivier Mulisya ; Dalton Kambale Munyambalu [Ouganda] ; Gabriel Kambale Bunduki | Ebola in the Eastern Democratic Republic of Congo: One Health approach to infectious disease control. |
| 000701 (2020) |
Adam J. Kucharski [Royaume-Uni] ; Timothy W. Russell [Royaume-Uni] ; Charlie Diamond [Royaume-Uni] ; Yang Liu [Royaume-Uni] ; John Edmunds [Royaume-Uni] ; Sebastian Funk [Royaume-Uni] ; Rosalind M. Eggo [Royaume-Uni] | Early dynamics of transmission and control of COVID-19: a mathematical modelling study |
| 000747 (2020) |
Md Insiat Islam Rabby [Malaisie] | Current Drugs with Potential for Treatment of COVID-19: A Literature Review. |
| 000757 (2020) |
Lei Zha [République populaire de Chine] ; Shirong Li [République populaire de Chine] ; Lingling Pan [République populaire de Chine] ; Boris Tefsen [République populaire de Chine] ; Yeshan Li [République populaire de Chine] ; Neil French [Royaume-Uni] ; Liyun Chen [République populaire de Chine] ; Gang Yang [République populaire de Chine] ; Elmer V. Villanueva [République populaire de Chine] | Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19). |
| 000759 (2020) |
Giuseppe Rombolà [Italie] ; Marco Heidempergher [Italie] ; Luciano Pedrini [Italie] ; Marco Farina [Italie] ; Filippo Aucella [Italie] ; Piergiorgio Messa [Italie] ; Giuliano Brunori [Italie] | Correction to: Practical indications for the prevention and management of SARS-CoV-2 in ambulatory dialysis patients: lessons from the first phase of the epidemics in Lombardy |
| 000780 (2020) |
Erin K. Mccreary [États-Unis] ; Jason M. Pogue [États-Unis] | Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options |
| 000821 (2020) |
Sandro G. Viveiros Rosa [Brésil] ; Wilson C. Santos [Brésil] | Clinical trials on drug repositioning for COVID-19 treatment |
| 000828 (2020) |
Chun Liu [République populaire de Chine] ; Changhui Wu [République populaire de Chine] ; Xiangde Zheng [République populaire de Chine] ; Fanwei Zeng [République populaire de Chine] ; Jinping Liu [République populaire de Chine] ; Pingxi Wang [République populaire de Chine] ; Fanxin Zeng [République populaire de Chine] ; Lin Yuan [République populaire de Chine] ; Fangcheng Zhu [République populaire de Chine] ; Xuemei Gan [République populaire de Chine] ; Yucheng Huang [République populaire de Chine] | Clinical features and multidisciplinary treatment outcome of COVID-19 pneumonia: A report of three cases |
| 000874 (2020) |
Timothy P. Hanna ; Gerald A. Evans ; Christopher M. Booth | Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic |
| 000880 (2020) |
Annelies Wilder-Smith [Royaume-Uni, Allemagne, Singapour] ; Calvin J. Chiew [Singapour] ; Vernon J. Lee [Singapour] | Can we contain the COVID-19 outbreak with the same measures as for SARS? |
| 000897 (2020) |
Rui Zhang [République populaire de Chine] ; Xuebin Wang [République populaire de Chine] ; Leng Ni [République populaire de Chine] ; Xiao Di [République populaire de Chine] ; Baitao Ma [République populaire de Chine] ; Shuai Niu [République populaire de Chine] ; Changwei Liu [République populaire de Chine] ; Russel J. Reiter [États-Unis] | COVID-19: Melatonin as a potential adjuvant treatment. |
| 000915 (2020) |
Mrudula Phadke [Inde] ; Sujata Saunik [Inde] | COVID-19 treatment by repurposing drugs until the vaccine is in sight. |
| 000930 (2020) |
Nicola Decaro [Italie] ; Vito Martella [Italie] ; Linda J. Saif [États-Unis] ; Canio Buonavoglia [Italie] | COVID-19 from veterinary medicine and one health perspectives: What animal coronaviruses have taught us. |
| 000933 (2020) |
Tomasz Dzieciatkowski [Pologne] ; Lukasz Szarpak [Pologne] ; Krzysztof J. Filipiak [Pologne] ; Milosz Jaguszewski [Pologne] ; Jerzy R. Ladny [Pologne] ; Jacek Smereka [Pologne] | COVID-19 challenge for modern medicine. |
| 000947 (2020) |
R. Izzetti [Italie] ; M. Nisi [Italie] ; M. Gabriele [Italie] ; F. Graziani [Italie] | COVID-19 Transmission in Dental Practice: Brief Review of Preventive Measures in Italy. |
| 000961 (2020) |
Pengfei Sun [République populaire de Chine] ; Xiaosheng Lu [République populaire de Chine] ; Chao Xu [République populaire de Chine] ; Yanjin Wang [République populaire de Chine] ; Wenjuan Sun [République populaire de Chine] ; Jianing Xi [République populaire de Chine] | CD-sACE2 inclusion compounds: An effective treatment for coronavirus disease 2019 (COVID-19). |
| 000964 (2020) |
Jianjun Gao [République populaire de Chine] ; Zhenxue Tian [République populaire de Chine] ; Xu Yang [République populaire de Chine] | Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. |
| 000970 (2020) |
Eric J. Rubin ; Lindsey R. Baden ; Stephen Morrissey | Audio Interview: Practical Measures to Help Prevent Covid-19. |
